Compelling evidence from in vivo experiments demonstrates the efficacy of glibenclamide in rapidly reversing hypotension in these animals, implicating the hyperactivity of Kir6.1/SUR2B channels in the pathogenesis of sepsis-induced hypotension [45]. This evidence concerns the gene KCNJ8 and Sepsis.